BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18297586)

  • 1. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale.
    Carroll BT; Lee JW; Graham KT; Thalassinos A; Thomas C; Kirkhart R
    Ann Clin Psychiatry; 2008; 20(1):47-8. PubMed ID: 18297586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW
    J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Catatonic syndrome and neuroleptic malignant syndrome].
    Ruzikowska A
    Psychiatr Pol; 1999; 33(3):415-25. PubMed ID: 10786241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rating scale for neuroleptic malignant syndrome.
    Sachdev PS
    Psychiatry Res; 2005 Jun; 135(3):249-56. PubMed ID: 15996751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison].
    Schröder J; Linge C; Wähner A
    Fortschr Neurol Psychiatr; 1988 Mar; 56(3):97-101. PubMed ID: 2896144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
    Perry PJ; Wilborn CA
    Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ; Tuite PJ
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
    Topka H; Buchkremer G
    Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
    Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Are catatonia and neuroleptic malignant syndrome related conditions?].
    Vesperini S; Papetti F; Pringuey D
    Encephale; 2010 Apr; 36(2):105-10. PubMed ID: 20434626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
    Kontaxakis VP; Vaidakis NM; Christodoulou GN; Valergaki HC
    Neuropsychobiology; 1990; 23(1):38-40. PubMed ID: 2280828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catatonia and the neuroleptic malignant syndrome--a single entity?
    White DA
    Br J Psychiatry; 1992 Oct; 161():558-60. PubMed ID: 1393347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G; Susman VL
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMS and lethal catatonia.
    Weller M
    J Clin Psychiatry; 1992 Aug; 53(8):294-5. PubMed ID: 1500409
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe catatonia and neuroleptic malignant syndrome: report of 3 cases.
    Kasantikul D; Kanchananakhin P
    J Med Assoc Thai; 1999 Sep; 82(9):942-6. PubMed ID: 10561954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome and catatonia: one entity or two?
    Fink M
    Biol Psychiatry; 1996 Jan; 39(1):1-4. PubMed ID: 8719118
    [No Abstract]   [Full Text] [Related]  

  • 19. Dr. Ananth replies to Drs. Carroll and Lee "catatonia is a risk factor for neuroleptic malignant syndrome".
    Ananth J
    J Clin Psychiatry; 2005 Jan; 66(1):134. PubMed ID: 15669900
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A; Lesch KP
    Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.